Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer Genomics and Diagnostics, and BRCA gene mutations in cancer.
Setting higher standards for reports of microbial species in human cancers.
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities
Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial.
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy.
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
Absence of lipopolysaccharide (LPS) expression in breast cancer cells.
Conquering Overtreatment of DCIS: Lessons from PRECISION.
Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.
Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features
Watchful waiting for ductal carcinoma in situ: are we ready to step back?
Capturing breast cancers' copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond.
Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ.
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance.
Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade.
Archival single-cell genomics reveals persistent subclones during DCIS progression
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer
Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study
Tumour-educated platelets for breast cancer detection: biological and technical insights.
Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study
Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis.
Absence of Lipopolysccharide (LPS) expression in Breast Cancer Cells
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.
Author Correction: Learning to distinguish progressive and non-progressive ductal carcinoma in situ.